Option Care Health, Inc. (NASDAQ:OPCH) Stock Has Consensus Price Target of $29.48 According to Analysts

Posted by George Bondi on Nov 6th, 2026

Shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) have earned a consensus rating of “Hold” from the sixteen analysts that are presently covering the firm, Marketbeat reports. Fourteen research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $29.48.

OPCH has been the subject of a number of recent research reports. Citizens Jmp downgraded shares of Option Care Health from a “market outperform” rating to a “hold” rating in a research note on Wednesday, October 7th. Weiss Ratings raised Option Care Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 20th. Truist Financial set a $32.05 target price on Option Care Health in a research report on Wednesday, October 7th. Morgan Stanley set a $32.05 price target on Option Care Health in a report on Monday, October 12th. Finally, UBS Group lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $39.00 to $32.05 in a research report on Friday, October 9th.

View Our Latest Stock Analysis on OPCH

Key Stories Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

Positive Sentiment: Q3 revenue rose 4.1% year over year to $1.49 billion, topping the roughly $1.48 billion analyst estimate. Adjusted EPS was $0.49, up from $0.45 a year earlier; it met the broader consensus, though Zacks cited an estimate of $0.48. Company Q3 results Zacks Q3 earnings report
Neutral Sentiment: A law firm announced an investigation into whether the proposed OPCH merger offers shareholders a fair deal. This is an inquiry, not a finding of wrongdoing, but it may add some deal-related uncertainty. Merger investigation announcement
Negative Sentiment: Option Care withdrew its financial guidance due to the pending merger. The lack of updated targets limits visibility into expected performance and may temper the positive reaction to the quarterly results. Q3 results and guidance withdrawal

Option Care Health Trading Down 0.5%

NASDAQ:OPCH opened at $31.50 on Friday. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.98 and a current ratio of 1.54. The firm has a market cap of $4.72 billion, a P/E ratio of 19.54, a P/E/G ratio of 1.92 and a beta of 0.47. The firm has a 50-day simple moving average of $27.14 and a 200-day simple moving average of $26.39.

Option Care Health (NASDAQ:OPCH – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. Option Care Health had a net margin of 3.74% and a return on equity of 19.06%. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the prior year, the company earned $0.45 EPS. The company’s revenue was up 4.1% compared to the same quarter last year. Equities analysts anticipate that Option Care Health will post 1.70 EPS for the current fiscal year.

Hedge Funds Weigh In On Option Care Health

Several institutional investors and hedge funds have recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its holdings in shares of Option Care Health by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock valued at $104,368,000 after purchasing an additional 36,208 shares during the last quarter. Southpoint Capital Advisors LP lifted its position in Option Care Health by 20.0% during the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock worth $96,912,000 after buying an additional 600,000 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. purchased a new position in Option Care Health during the first quarter worth approximately $70,287,000. Van Berkom & Associates Inc. boosted its stake in Option Care Health by 18.2% during the third quarter. Van Berkom & Associates Inc. now owns 2,583,253 shares of the company’s stock worth $58,097,000 after buying an additional 397,369 shares during the last quarter. Finally, Bank of America Corp DE boosted its stake in Option Care Health by 14.6% during the first quarter. Bank of America Corp DE now owns 1,945,015 shares of the company’s stock worth $52,360,000 after buying an additional 247,766 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

About Option Care Health

(Get Free Report)

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.